hRFI overexpressed in HCT116 cells modulates Bcl-2 family proteins when treated with 5-fluorouracil

  • Authors: Shin Sasaki, Toshiaki Watanabe, Takashi Kobunai, Tsuyoshi Konishi, Hideki Nagase, Yoshikazu Sugimoto, Toshinori Oka, Hirokazu Nagawa
  • View Affiliations

  • Published online on: Monday, May 1, 2006
  • Pages: 1293-1298
  • DOI: 10.3892/or.15.5.1293

Abstract

Exogenous overexpression of hRFI, originally isolated in our laboratory, inhibits not only death receptor-mediated apoptosis but also the mitochondrial apoptosis induced by several chemotherapeutic agents including 5-fluorouracil (5-FU). Recently, it has become clear that hRFI targets and degradates caspase-8 and -10 in death receptor-mediated apoptosis by E3 ubiquitin activity in a ring finger domain homologous to that of X-chromosome-linked inhibitor of apoptosis protein (XIAP). However, the cellular mechanism of the inhibition of mitochondrial apoptosis by hRFI has not been fully elucidated. We prepared HCT116 overexpressing hRFI (HCT116/hRFI) cells and comprehensively analyzed the expression changes of 51 apoptosis-related genes with or without 5-FU treatment between HCT116/hRFI and mock cells using microfluidic low-density arrays. As a result, we identified four genes (Bcl-2, Bcl-XL, cIAP2, and CFLAR) whose expression was four or more times higher in HCT116/ hRFI cells than in HCT116/LacZ cells, and found that Bcl-2 and the ratio of Bcl-2/Bax or Bcl-2/Bak were upregulated when HCT116/hRFI cells were treated with 5-FU. Furthermore, we also validated the up-regulation of Bcl-2 and Bcl-XL in HCT116/hRFI cells treated with 5-FU by Western blot analysis. Such evidence suggests that the modulation of Bcl-2 family proteins seen in 5-FU treatment plays an important role in the anti-apoptotic function of HCT116/hRFI cells.
Journal Cover

May 2006
Volume 15 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

2013 Impact Factor: 2.191
Ranked #33/202 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Sasaki, S., Watanabe, T., Kobunai, T., Konishi, T., Nagase, H., Sugimoto, Y., Oka, T., & Nagawa, H. (2006). hRFI overexpressed in HCT116 cells modulates Bcl-2 family proteins when treated with 5-fluorouracil. Oncology Reports, 15(5), 1293-1298.
MLA
Sasaki, Watanabe, Kobunai, Konishi, Nagase, Sugimoto, Oka, and Hirokazu Nagawa. "hRFI overexpressed in HCT116 cells modulates Bcl-2 family proteins when treated with 5-fluorouracil." Oncology Reports Oncology Reports 15.5 (2006): 1293-1298.
Chicago
Sasaki, Watanabe, Kobunai, Konishi, Nagase, Sugimoto, Oka, and Hirokazu Nagawa. "hRFI overexpressed in HCT116 cells modulates Bcl-2 family proteins when treated with 5-fluorouracil." Oncology Reports Oncology Reports 15 no. 5 (2006): 1293-1298.